Found 24 matching trials
Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)
PHASE3This study was to compare the safety and efficacy of the preservative-free ...
Location
Multiple Locations
24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy
PHASE4The study investigated the 24-hour efficacy and ocular surface health with ...
Location
Multiple Locations
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety
PHASE4The goal of this study is to evaluate the tolerability of the new formulati...
Location
Clínica de Ojos Dr. Nano
A Study to Evaluate Safety and Tolerability of QLS-101 in NTG
PHASE2A randomized active-controlled multi-site double-masked 28 day study to eva...
Location
Vance Thompson Vision
Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).
PHASE2Evaluating the safety and tolerability of QLS-101 versus timolol maleate op...
Pharmacokinetics, Safety and Tolerability of the Preservative-free Fixed Dose Combination of Tafluprost 0.0015% and Timolol 0.5% Eye Drops
PHASE1The objective of this study is to investigate the pharmacokinetics, safety ...
Location
Kuopio University Hospital Eye Clinic
Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing
PHASE4The ideal dosing for preservative-free tafluprost/timolol fixed combination...
Location
1st University Department of Ophthalmology
Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®
PHASE1Therapeutic indication: Ocular hypotensive Use: Primary open-angle glaucoma...
Location
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients
PHASE4Glaucoma is an optic neuropathy in which the main risk factor is intraocula...
Location
University Hospitals Leuven
From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy
NAThere is a lack of evidence on the impact of switching from a combined pres...
Location
University Department of Ophthalmology